N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study
Authors:
- Madeline R. SterlingMSMadeline R. Sterling
- Raegan W. DurantRDRaegan W. Durant
- Joanna BryanJBJoanna Bryan
- Emily B. LevitanELEmily B. Levitan
- Todd M. BrownTBTodd M. Brown
- Yulia KhodnevaYKYulia Khodneva
- Stephen P. GlasserSGStephen P. Glasser
- Joshua S. RichmanJoshua S. Richman
- George HowardGHGeorge Howard
- Mary CushmanMCMary Cushman
- Monika M. SaffordMSMonika M. Safford
Open Access
- 16 April 2018
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 18 (1) , 66
Abstract
N-terminal pro B-type peptide (NT-proBNP) has been associated with risk of myocardial infarction (MI), but less is known about the relationship between NT-proBNP and very small non ST-elevation MI, also known as microsize MI. These events are now routinely detectable with modern troponin assays and are emerging as a large proportion of all MI. Here, we sought to compare the association of NT-proBNP with risk of incident typical MI and microsize MI in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. The REGARDS Study is a national cohort of 30,239 US community-dwelling black and white adults aged ≥ 45 years recruited from 2003 to 2007. Expert-adjudicated outcomes included incident typical MI (definite/probable MI with peak troponin ≥ 0.5 μg/L), incident microsize MI (definite/probable MI with peak troponin < 0.5 μg/L), and incident fatal CHD. Using a case-cohort design, we estimated the hazard ratio of the outcomes as a function of baseline NT-proBNP. Competing risk analyses tested whether the associations of NT-proBNP differed between the risk of incident microsize MI and incident typical MI as well as if the association of NT-proBNP differed between incident non-fatal microsize MI and incident non-fatal typical MI, while accounting for incident fatal coronary heart disease (CHD) as well as heart failure (HF). Over a median of 5 years of follow-up, there were 315 typical MI, 139 microsize MI, and 195 incident fatal CHD. NT-proBNP was independently and strongly associated with all CHD endpoints, with significantly greater risk observed for incident microsize MI, even after removing individuals with suspected HF prior to or coincident with their incident CHD event. NT-proBNP is associated with all MIs, but is a more powerful risk factor for microsize than typical MI.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (U01 NS041588)
- Agency for Healthcare Research and Quality (T32HS000066)
This publication has 47 references indexed in Scilit:
- Cardiovascular Biomarkers and Subclinical Brain Disease in the Atherosclerosis Risk in Communities StudyStroke, 2013
- Hospital laboratory reporting may be a barrier to detection of ‘microsize’ myocardial infarction in the US: an observational studyBMC Health Services Research, 2013
- B-type natriuretic peptide is an independent predictor of endothelial function in manClinical Science, 2012
- Evaluation and Comparison of the Minnesota Code and Novacode for Electrocardiographic Q-ST Wave Abnormalities for the Independent Prediction of Incident Coronary Heart Disease and Total Mortality (from the Women's Health Initiative)The American Journal of Cardiology, 2010
- Implications of Increased C-Reactive Protein for Cardiovascular Risk Stratification in Black and White Men and Women in the USClinical Chemistry, 2009
- N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP), Cardiovascular Events, and Mortality in Patients With Stable Coronary Heart DiseaseJAMA, 2007
- Effect of Compensated Renal Dysfunction on Approved Heart Failure MarkersHypertension, 2005
- Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fractionThe American Journal of Cardiology, 2005
- Evidence-based decision limits for cardiac troponin: Low-level elevation and prognosisAmerican Heart Journal, 2004
- Multiple imputation in health‐are databases: An overview and some applicationsStatistics in Medicine, 1991